Peak6 Investments LLC Axsome Therapeutics, Inc. Call Options Transaction History

Peak6 Investments LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$65.72 - $80.5 $486,328 - $595,700	-7,400 Reduced 49.66%	7,500 $603,000
Q1 2024 May 14, 2024	SELL	$69.39 - $97.64 $888,192 - $1.25 Million	-12,800 Reduced 46.21%	14,900 $1.19 Million
Q4 2023 Feb 13, 2024	BUY	$57.42 - $83.61 $671,814 - $978,237	11,700 Added 73.13%	27,700 $2.2 Million
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $1.66 Million - $1.97 Million	-24,000 Reduced 60.0%	16,000 $1.12 Million
Q2 2023 Aug 11, 2023	BUY	$58.41 - $90.35 $2.04 Million - $3.16 Million	35,000 Added 700.0%	40,000 $2.87 Million
Q4 2022 Feb 10, 2023	BUY	$39.94 - $79.72 $199,700 - $398,600	5,000 New	5,000 $386,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.